NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Labviva

Labviva

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://labviva.com

Last Round

Series B

Jan 13, 2025

Total Funding Raised

$55M

Company Overview

Labviva is a SaaS and artificial intelligence company that operates an AI-powered digital marketplace intended to offer better visibility into life science supply chains.

Sector

Healthcare & Life Sciences

Verticals

Vertical SaaS, Pharma Supply Chain, E-commerce, Business Intelligence, Workflow Automation

Business Model

B2B

Customer Profile

Marketplace Commission, Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

laboratory procurementlife science marketplacee-procurement integrationprocure-to-paylab supply chainpunchout integrationprocurement softwareAI procurementspend managementlab reagentsenterprise resource planningERPSaaS procurementAI agentic workflowsupply chain visibility

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Labviva Comps

Public and private peers based on sector, stage, and business model.

Labviva comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Labviva Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJan 13, 2025
Series AMar 27, 2023
SeedJun 2, 2021
Pre SeedAug 4, 2020

Key People

Founding team and executive leadership

Nicholas Rioux

CTO & Co-Founder

Founding Team

Siamak Baharloo

Chief Executive Officer

Executive Team

Labviva Investors

Notable investors and investment history

Labviva investors
InvestorRounds
Biospring PartnersSeries B, Series A
B Capital GroupSeries B, Series A, Seed
Tech Coast AngelsPre Seed
Senator Investment GroupSeries A, Seed
53 StationsSeries B
Glasswing VenturesSeries B, Series A, Seed, Pre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 27, 2025

    Launched 'Smart Suppliers of the Future' AI platform.

  • Jun 27, 2025

    Harper Chemical (HarperChem) is now generally available.

Labviva Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Labviva Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Labviva's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range67
Year Founded2017
Last FundingJan 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.